CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended
	Oct. 31, 2016	Oct. 31, 2015
Operating Expenses:
Research and development		$ 177,570
General and administrative	102,818	1,140,009
Total Operating Expenses	102,818	1,317,579
Operating Loss	(102,818)	(1,317,579)
Other Income/(Expense):
Interest expense	(116,839)	(97,723)
Change in fair value of derivative liabilities (Note 8)	779,895	(315,963)
Net (Loss) / Income and Net Income (Loss) Available to Common Stockholders	$ 560,238	$ (1,731,265)
Basic and Diluted Net Income (Loss) Per Common Share (Note 6)	$ .001	$ (.002)
Weighted Average Number of Shares of Common Stock Outstanding - basic and diluted	908,541,475	850,126,309
Other Comprehensive (Loss) / Income
Net Income	$ 560,238	$ (1,731,265)
Change in foreign currency translation adjustments	7,174	(2,936)
Comprehensive (Loss) / Income	$ 567,412	$ (1,734,201)